Bisphenol A [2,2-bis(4-hydoxyphenyl)propane; BPA] is an endocrine disrupter widely used in polycarbonate plastics and epoxy resins. We investigated the effects of orally administered BPA on antigen-specific responses of the naïve immune system.
Xenoestrogens (XEs), also called environmental estrogens, are varied chemical compounds suspected of disrupting and interfering with the functions of the endocrine system, homeostasis, and the regulation of developmental processes in wildlife species and humans. 1, 2) Today, potential exposures to several XEs has become a contentious health concern as well as an environmental issue. 3, 4) Bisphenol A (BPA), one type of the XE, is widely used in producing polycarbonate plastics and epoxy resins, which are used in dental care, food packaging, and the inner coating of food cans, bottle tops, and water pipes. 5, 6) It is a hydrophobic compound and has a low aqueous solubility. However, a certain level of BPA has been detected in autoclaved canned foods and in the saliva of dental patients who have had their teeth filled. 7, 8) BPA is considered to act as a weaker estrogen, about 1,000-to 2,000-fold less potent than 17-estradiol when interacting with classical estrogen receptors. 7, 9) Exposure of experiment animals to BPA has been reported to have significant effects on reproductive organs, such as uterotrophic effects, 10) decreases in sperm production, 1, 3, 11) stimulation of prolactin release, 12, 13) and influences on embryonic development. 4, 14) Estrogen is thought to regulate not only the genital system but also the immune system. 15, 16) Therefore, it is expected that XEs exhibit estrogenic effects on the immune system. In fact, there are some reports that XEs, including BPA, might affect the immune system as well as the endocrine system. Jontell 17) and Goto 18) found that the proliferation of immune cells induced by concanavalin A was augmented with the addition of BPA in vitro.
In vivo experiments are very important for estimating the effects of BPA on human health because the majority of administered BPA is metabolized to BPA-monoglucuronide, which has no estrogenic activity and is excreted immediately. 19, 20) Therefore, the effects of BPA at its actual concentration in the body should be investigated. Some reports have indicated that the exposure of mice to BPA affected their antigen-specific immune responses. Tian 21) suggested that the production of Th2-type cytokines y To whom correspondence should be addressed. Fax: +81-29-838-8055; E-mail: yuko@affrc.go.jp Abbreviations: APCs, antigen presenting cells; BPA, bisphenol A; DMSO, dimethyl sulfoxide; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; IFN, interferon; mAb, monoclonal antibody; XEs, xenoestrogens markedly increased in Trichinella spiralis infected mice inoculated orally with BPA. Yoshino 22) reported that orally administered BPA can play a role in augmenting immune responses, especially Th1-type responses in mice immunized with hen-egg lysozyme.
In order to investigate these antigen-specific immune responses, experimental animal models must be immunized with the antigen parenterally or with infections of bacterial strains in advance. Consequently, the effects of BPA in these studies were estimated under inflammatory and T cell activating conditions. A detoxication system through glucuronidation waned under inflammatory conditions, 23, 24) and Th1/2-differentiation of T cells occurred in the period of T cell activation. These experimental systems did not detect the effects of BPA on the naïve immune system, and most people, likely exposed to BPA are not thought to be in an inflammatory condition.
Therefore, we investigated the effects of orally administered BPA on antigen-specific immune responses using T cell receptor (TCR) transgenic mice that did not need to be immunized with the antigen to analyze the effects of BPA on their immune responses under non-inflammatory and T cell resting states.
Materials and Methods
Mice. DO11.10 mice that expressed TCR specific for ovalbumin (OVA) 323-339 bound with I-Ad were purchased from Jackson Laboratory (Boston, MA, USA) and maintained in our specific pathogen-free animal facilities. Homozygotes were mated with BALB/c mice to produce the heterozygotes that were used with these experiments. Eight-to 15-week-old mice (both male and female) were used.
All animal experiments were performed in accordance with the guidelines of the National Food Research Institute for Animal Experiments and the Law (no. 105) and Notification (no. 6) of the Japanese Government.
Chemicals and reagents. RPMI1640 medium was purchased from Sigma (St. Louis, MO, USA). Chicken egg albumin (OVA) Fraction V was purchased from Seikagaku Kogyo (Tokyo, Japan). BPA and dimethyl sulfoxide (DMSO) were purchased from Wako Pure Chemical Industries (Osaka, Japan). All other chemicals were of the highest purity available from commercial sources.
Administration of BPA. BPA was dissolved in DMSO at a concentration of 40 mg/ml and then diluted with deionized water. The final concentration of the solution was adjusted to 10 mg/l of BPA with 0.025% of DMSO. Water containing BPA at 10 mg/l was provided ad libitum instead of pure drinking water for two weeks. Deionized water containing 0.025% of DMSO was given as a control.
Cells culture. Splenocytes and splenic T cells from the mice were stimulated with OVA (splenocytes) and anti-CD3 mAb (splenic T cells) and cultured in a culture medium. This culture medium was RPMI1640, containing 2-mercaptoethanol (5 Â 10 À5 mol/l), penicillin (100 U/ml), streptomycin (100 mg/ml), and 10% fetal calf serum (ICN Biomedicals., Irvine, CA, USA).
Antigen-specific cell proliferation assay in vitro. The splenocytes from the mice were suspended at 1 Â 10 5 cells/well in 96-well culture plates (NUNK, Boston, MA, USA) with 100 ml/well of the culture medium and stimulated with OVA at 5 mM and 10 mM. After 72 h, cell proliferation was measured by cell proliferation enzymelinked immunosorbent assay (ELISA), BrdU (chemiluminescent) kit (Roche Molecular Biochemicals, Basel, Switzerland).
ELISA for measuring cytokines and antibodies in culture supernatant. The culture supernatants were collected at 48 h (for measurement of IL-2, 4, and 5), at 72 h (for IL-10 and IFN-), and at 7 d (for IgG1, IgG2a, IgM, and IgA) after OVA stimulation, and stored at À30
C. The concentration of cytokines was measured using Mouse ELISA Ready Set Go!-kits (eBioscience, San Diego, CA, USA), and the concentration of antibodies was measured using the Mouse Ig ELISA Quantitation Kits (Bethyl, Montgomery, TX, USA).
Cell separation. T cells and antigen presenting cells (APCs) were separated from splenocytes by the MACS system (Miltenyi Biotech, Bergisch Gladbach, Germany), as described by the manufacturer. Splenocytes were treated with anti-CD4 microbeads and separated as antigen-specific T cells (positive fraction), and APCs (negative fraction). Further, APCs were treated with anti-Mac1 microbeads and sorted as positive and negative fractions, as Mac1 þ APCs and Mac1 À APCs respectively. After MACS separation, the purity of the respective cells was > 96%.
Cytokine production by whole splenocytes. The splenocytes were suspended at 1 Â 10 6 cells/well in the 48-well culture plates and stimulated in the culture medium with OVA in a total volume of 500 ml.
Cytokine production by T cells stimulated with anti-CD3 mAb. Separated T cells (0:5 Â 10 5 cells/well) were stimulated with plate-coated 0.5 mg/ml anti-CD3 mAb (145-2C11, eBioscience, San Diego, CA, USA) in a 96-well plate in a total volume of 100 ml. 
Results

Effect of orally administered BPA on antigen-specific proliferation of splenocytes
The antigen-specific cell proliferations of splenocytes prepared from BPA-treated and control mice were compared. As depicted in Fig. 1 , there was a decreasing tendency in the antigen-specific cell proliferation stimulated with 5 mM of OVA in BPA intake mice, but this was not significant.
Effects of orally administered BPA on antigen-specific antibody production of splenocytes
The antigen-specific antibody production amounts of splenocytes are presented in Fig. 2 . In the BPA intake group, IgM production stimulated with 5 mM of OVA decreased significantly (Fig. 2a ). In addition, there was a decreasing tendency in the antigen-specific production of IgG1, which is representative Th2-type antibody, in BPA intake groups, but this was not significant (Fig. 2b) . In contrast, production of IgG2a, which is a representative Th1-type antibody, stimulated with 5 mM of OVA, and IgA production stimulated with 10 mM of OVA in the BPA-treated mice, increased significantly as compared the control group (Fig. 2c, d ).
Effect of orally administered BPA on antigen-specific cytokine secretion from splenocytes Cytokine concentrations in the culture supernatant of specific-antigen stimulated splenocytes are shown in Fig. 3 . There were significant differences between the control groups and the BPA intake groups in the concentrations of IL-2, IL-4, and IFN-stimulated with 5 mM of OVA, and these cytokine production were inclined to decrease in the BPA intake group (Fig. 3a, b,  c) . Conversely, there were no differences in IL-5 and IL-10 secretion as between the BPA intake group and the control group (Fig. 3d, e) .
To determine the effects of BPA on the Th1/2-differentiation of splenic T cells, the IFN-/IL-4 was calculated as a Th1/2 score from the data above (Fig. 4) . The difference was not significant, but there was a tendency for the Th1/2 score to be higher in the BPA intake group.
To investigate which cells in splenocytes were involved with the effects of orally administered BPA, cells from splenocytes were sorted.
To estimate the effects of BPA administration on T cells, antigen-specific cytokine production in the coculture system of T cells and APCs was carried out. Co-culture of T cells from the control and BPA intake groups and APCs from the control groups was carried out. T cells and APCs were co-cultured with 10 mM of OVA, and production of cytokines (IL-2, 4, and IFN-) was compared (Fig. 5a, b, c) . The results suggest that IL-2 and IL-4 production of T cells from BPA-treated mice (BPA-T cells) was similar to that from control mice (control-T cells), but that IFN-production of BPA-T cells increased clearly.
Added to this, the cytokine production of control-T cells and BPA T cells stimulated with anti-CD3 mAb were compared (Fig. 6a, b, c ). There were no great differences between the control groups and the BPA intake groups in the secretion of cytokines from T cells.
To estimate the effects of BPA administration on each type of APCs, co-culture of T cells from the control groups and APCs from both the control (control-APCs) and BPA intake groups (BPA-APCs) were carried out (Fig. 7a, b, c) . Mac1 þ APCs from the BPA intake mice showed a tendency to increase in antigen-specific cytokine production, whereas APCs and Mac1 À APCs showed a tendency to suppress antigen-specific cytokines production.
Discussion
The number of patients with allergic diseases has recently been increasing in developed countries. The relationship between environmental chemicals and the immune system 25, 26) has been attracting attention, and recent research data on the effects of endocrine disruptors on cells and animals is accumulating.
BPA is a representative endocrine disruptor, and effects on the genital system are frequently reported, however there are a limited number of reports on its effects on the immune system have been published. Hence, we studied the effects of BPA on antigen-specific immune responses when immunologic naïve mice were orally administered BPA continuously. In this study, we used DO11.10 mice that expressed OVA-specific TCR
OVA (µM)
OVA ( innately and responded to OVA without preimmunization.
The results indicate that continuous oral administration of BPA brought about a moderation of antigenspecific proliferation (Fig. 1) and IgM and IgG1 production of splenocytes (Fig. 2a, b) .
We analyzed the abundance ratio of antigen-specific T cells in spleens by flowcytomation, but there was no difference between BPA-treated mice and control mice (data not shown). Furthermore, the total number of splenocytes also exhibited no difference. These results indicate that the disorders of immune responses in BPAadministered mice were brought about by impaired functions of immunocytes and not by a decrease in the number of antigen-specific T cells.
Antigen-specific IgG2a and IgA production levels were significantly upregulated under BPA treatment (Fig. 2c, d ). IgG2a is a representative Th1-type antibody, and hence the augmentation in IgG2a was thought to be caused by a Th1-type differentiation in the cytokine pattern. In fact, our study indicates that splenocytes from BPA-administered mice tended to exhibit a Th1-type cytokine pattern when they were stimulated with a specific antigen (Fig. 4) . Alizadeh 27) and Yoshino 22) also reported that administering BPA results in strong augmentation of Th1-type immune responses especially in immunized mice.
When we compared antigen-specific cytokine production of control-T cells and BPA-T cells with controlAPCs, there were no differences between IL-2 and IL-4 production, and IFN-production of BPA-T cells increased (Fig. 5a, b, c) . Added to this, it was found that cytokine production by BPA-T cells stimulated with anti-CD3 mAb was similar to that of control-T cells (Fig. 6a, b, c) . These results suggest that co-stimulation from APCs was modified in BPA-T cells, increasing IFN-production.
On the other hand, antigen-specific IL-2, IL-4, and IFN-secretion of whole splenocytes tended to decrease in the BPA-intake group (Fig. 3a, b, c) . Hence it is suggested that BPA administration affected not only T cells but also APCs, in different ways. Hence co-culture of control-T cells and BPA-APCs was conducted to estimate the effects of BPA administration on APCs.
The co-culture systems revealed that APCs (T cells from which splenocytes had been removed) and Mac1 À APCs from the BPA intake group showed suppressive activity of production of these cytokines, and that T cells with Mac1 þ APCs from the BPA intake group increased in cytokine production (Fig. 7a, b, c) . Goto 18) reported that Mac1 þ splenocytes participated in the augmentation of splenic T cells with BPA in vitro, and it was suggested that orally administered BPA affected the functions of Mac1 þ splenocytes with effects similar to those in vitro. The recovery of Mac1 þ splenocytes was about 5% of whole splenocytes, and suppressive Mac1 À APCs are a major cell population in splenocytes. Hence it is suggested that whole BPAAPCs indicate activity suppressive of the cytokine production of T cells.
The IL-5 secretion of splenocytes from BPA administered mice was similar to that of the control mice (Fig. 3d) . IgA secretion largely depends on IL-5. Hence, it is suggested that the augmentation of IgA was brought about by maintenance of the IL-5 level and suppression of the other cytokines that adversely affected IL-5. It has been reported that antigen-specific IL-5 production of splenocytes from BPA-administered immunized mice was similar to that from control mice, 28) and it was suggested that the pathways of IL-5 production in T cells were resistant to BPA.
Various effects of BPA on immune responses have been reported. Most of the reported effects are strong, but they often contradict each other. For example, Alizadeh 27) and Yoshino 22) reported that administering BPA results in an augmentation of Th1-type immune responses, especially in immunized mice. In contrast, Lee 28) reported that increasing Th2-type cytokine production in CD4 þ T cells from immunized mice was observed under i.p. (intra peritoneal) administration of BPA. Tian 21) reported that Th2-type cytokine production by mesenteric lymph node cells increased markedly in Trichinella spiralis-infected mice inoculated orally with BPA. Our results indicate that the inhibitory effect of BPA on cytokine secretion was more effective on IL-4 than IFN-, and that therefore the immune responses developed a tendency to a Th1-type reaction, although the effects were not very strong (Fig. 4) . In speculation on the contradictions among these reports, the differences among routes, solvents, and the conditions of BPA administration in the study system must become a focal issue. The relative bioavailability of orally administered BPA was markedly lower than that of subcutaneous or i.p. administration. [29] [30] [31] Corn oil has often been used as a solvent in administration of BPA, 10, 22, 32, 33) and the bioavailability of hydrophobic compounds was improved by co-administration with oil. 34) The resulting level of BPA in the body in this study, in which deionized water was used basically as a matrix for administration, is thus considered to be lower than those in the experiments of other groups.
Furthermore, most experimental animals were immunized with antigens 22, 27, 28, 35) or were infected with bacteria 21) when the effects of BPA on antigen-specific immune responses were studied. These treatments usually set up acute systemic immunological reactions, including inflammation and T cell differentiation. Administered BPA was usually metabolized into BPAglucuronide in the liver and intestines, 10, 14, 36) and BPA-glucuronide does not influence reproductive organs. 10, 14, 19, 37, 38) However, under inflammatory conditions, the activity of -glucuronidase, which hydrolyzes glucuronide conjugates into free aglycones, increased, 23, 24) and expression of the MRP2 transporter, which excretes glucuronide conjugates, was suppressed. 39) Hence it was assumed that an elevation of BPA bioavailability under inflammatory conditions by immunization or infection enhanced immune responses. Furthermore, Th1/2-differentiation occurs during T cell activation. BPA in the body might be able to act upon Th1/2-differentiation more efficiently in the period of T cell activation.
In our experiments, BPA in water ingestion was calculated at 1.5 to 1.8 mg/kg mouse weight/d on average under naïve conditions, which means that the BPA intake in our study was somewhat less than in other experiments. Our study indicates that orally administered BPA increased antigen-specific IFN-production of T cells and modified whole APCs, suppressing antigen-specific cytokine production by T cells. As the result of each modification, antigen-specific cytokine production from whole splenocytes was partially suppressed (Figs. 3, 5, 7) , and led to moderate Th1-type immunoreactions under the naïve condition without immunization in vivo. Added to these, each APCs showed different behavior under the influence of BPA administration (Fig. 7) , and their sensitivities to BPA might to be different. These results suggest that the bioavailability of BPA has a complex effect on immune responses. Hence the effects of BPA on immune function varied according to the method of administration and the physical conditions of test subjects.
